Ana Henriques1,2, Cláudia Silva1,3, Mariana Santiago1,4, Maria João Henriques1,4, António Martinho2, Hélder Trindade2, José António Pereira da Silva1,4, Bruno Silva-Santos5, Artur Paiva6,7. 1. Faculty of Medicine, University of Coimbra, Coimbra, Portugal. 2. Blood and Transplantation Center of Coimbra, Portuguese Institute of the Blood and Transplantation, Coimbra, Portugal. 3. Department of Biochemistry, University of Aveiro, Aveiro, Portugal. 4. Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 5. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. 6. Blood and Transplantation Center of Coimbra, Portuguese Institute of the Blood and Transplantation, Coimbra, Portugal. artur.paiva@chuc.min-saude.pt. 7. Flow Cytometry Unit, Clinical Pathology Service, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Ed. S. Jeronimo, 3001-301, Coimbra, Portugal. artur.paiva@chuc.min-saude.pt.
Abstract
OBJECTIVE AND DESIGN: Here, we evaluated the distribution and functional profile of circulating CD27+ and CD27- γδ T-cell subsets in systemic sclerosis (SSc) patients to assess their potential role in this disorder. MATERIALS AND METHODS: Peripheral blood from 39 SSc patients and 20 healthy individuals was used in this study. The TCR-γδ repertoire, cytokine production and cytotoxic signatures of circulating γδ T-cell subsets were assessed by flow cytometry. Gene expression of EOMES, NKG2D and GZMA was evaluated by quantitative RT-PCR in both purified γδ T-cell subsets. RESULTS: Absolute numbers of γδ T-cell subsets were significantly decreased in SSc groups, likely reflecting their mobilization to the inflamed skin. Both γδ T-cell subsets preserved their relative proportions and Th1-type cytokine responses. However, cytotoxic properties showed significant disease-associated and subset-specific changes. SSc patients exhibited increased percentages of CD27+ γδ T cells expressing granzyme B or perforin and upregulated GZMA expression in diffuse cutaneous SSc. Conversely, EOMES and NKG2D were downregulated in both SSc γδ T-cell subsets vs. normal controls. Interestingly, patients with pulmonary fibrosis showed a biased TCR repertoire, with a selected expansion of effector Vγ9+ γδ T cells associated with increased frequency of cells expressing granzyme B, but decreased IFN-γ production. CONCLUSIONS: Significant alterations on circulating γδ T-cell subsets suggest a deregulated (increased) cytotoxic activity and thus enhanced pathogenic potential of CD27+ γδ T cells in SSc.
OBJECTIVE AND DESIGN: Here, we evaluated the distribution and functional profile of circulating CD27+ and CD27- γδ T-cell subsets in systemic sclerosis (SSc) patients to assess their potential role in this disorder. MATERIALS AND METHODS: Peripheral blood from 39 SSc patients and 20 healthy individuals was used in this study. The TCR-γδ repertoire, cytokine production and cytotoxic signatures of circulating γδ T-cell subsets were assessed by flow cytometry. Gene expression of EOMES, NKG2D and GZMA was evaluated by quantitative RT-PCR in both purified γδ T-cell subsets. RESULTS: Absolute numbers of γδ T-cell subsets were significantly decreased in SSc groups, likely reflecting their mobilization to the inflamed skin. Both γδ T-cell subsets preserved their relative proportions and Th1-type cytokine responses. However, cytotoxic properties showed significant disease-associated and subset-specific changes. SSc patients exhibited increased percentages of CD27+ γδ T cells expressing granzyme B or perforin and upregulated GZMA expression in diffuse cutaneous SSc. Conversely, EOMES and NKG2D were downregulated in both SSc γδ T-cell subsets vs. normal controls. Interestingly, patients with pulmonary fibrosis showed a biased TCR repertoire, with a selected expansion of effector Vγ9+ γδ T cells associated with increased frequency of cells expressing granzyme B, but decreased IFN-γ production. CONCLUSIONS: Significant alterations on circulating γδ T-cell subsets suggest a deregulated (increased) cytotoxic activity and thus enhanced pathogenic potential of CD27+ γδ T cells in SSc.
Entities:
Keywords:
CD27; Cytotoxicity; Gamma–delta T cells; Systemic sclerosis; Th1-type cytokine
Authors: David E Oppenheim; Scott J Roberts; Sarah L Clarke; Renata Filler; Julie M Lewis; Robert E Tigelaar; Michael Girardi; Adrian C Hayday Journal: Nat Immunol Date: 2005-08-14 Impact factor: 25.606
Authors: Miguel Chaves-Ferreira; Francisco d'Orey; Julie C Ribot; Mélanie Wencker; Natacha Gonçalves-Sousa; Jérémie Decalf; João P Simas; Adrian C Hayday; Bruno Silva-Santos Journal: J Immunol Date: 2010-10-29 Impact factor: 5.422
Authors: Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner Journal: Science Date: 2003-11-07 Impact factor: 47.728
Authors: Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman Journal: Genome Biol Date: 2002-06-18 Impact factor: 13.583
Authors: Michael Gernert; Hans-Peter Tony; Eva Christina Schwaneck; Ottar Gadeholt; Matthias Fröhlich; Jan Portegys; Patrick-Pascal Strunz; Marc Schmalzing Journal: Rheumatol Int Date: 2021-10-25 Impact factor: 3.580
Authors: Helena Migalovich Sheikhet; Jose Villacorta Hidalgo; Paul Fisch; Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Ilan Bank Journal: Front Immunol Date: 2018-04-13 Impact factor: 7.561